Cibc World Markets Corp Novo Cure LTD Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Novo Cure LTD stock. As of the latest transaction made, Cibc World Markets Corp holds 23,631 shares of NVCR stock, worth $388,729. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,631
Previous 9,966
137.12%
Holding current value
$388,729
Previous $296,000
42.23%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$200 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$185 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$147 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$90.8 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$85.8 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.73B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...